AMAlexandra L. McCarthy

Alexandra L. McCarthy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra L. McCarthy has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transdisciplinary allied health assessment for patients with stroke: a pre-/post- mixed methods study protocol

    by Aleysha K. Martin, Theresa L. Green, Alexandra L. McCarthy, P. Marcin Sowa, E-Liisa Laakso

    Background: Transdisciplinary approaches can streamline processes and build workforce capacity by blurring traditional responsibilities and integrating aspects of care. Emerging evidence shows transdisciplinary approaches can improve time-efficiency, quality of care and cost-effectiveness across various healthcare settings, however no empirical study is based on an acute stroke unit. Methods: The SPIRIT checklist was used to guide the content of the research protocol. The study is a pragmatic pre−/post- mixed methods four-phase study with a 3-month follow up, based at the Mater Hospital Brisbane. Participants experiencing stroke symptoms will be recruited as they are admitted to the acute stroke unit. Patients presenting with mild stroke symptoms or Transient Ischaemic Attack will be allocated to Phase 1 (baseline) or Phase 2 (implementation), while patients presenting with moderate to severe stroke symptoms will be allocated to Phase 3 (baseline) or Phase 4 (implementation). Participants in baseline Phases 1 and 3 will receive standard allied health assessment, while participants in implementation Phases 2 and 4 will receive the novel transdisciplinary assessment. For the primary aim, allied health professionals will time their assessments to evaluate time taken to administer a novel transdisciplinary assessment, compared to usual discipline-specific assessments. Non-inferiority of the novel transdisciplinary assessment will also be explored in terms of patient safety, compliance to national standards, use of the assessment, and stakeholder perceptions. A retrospective medical record audit, staff focus group, patient/staff surveys, and patient phone interviews at 3-months will be completed. Quantitative results will be estimated using general linear and logistic regression models in Stata 15.1. Qualitative results will be analysed using frequency counts and NVivo software. An economic evaluation will be performed using three scopes including the allied health assessment, hospital admission, and patient outcomes at 3-months. Discussion: When designing the study, pragmatic factors related to staff willingness to be involved, patient safety, and existing clinical pathways/processes were considered. To address those factors, a co-design approach was taken, resulting in staff buy-in, clinically relevant outcome measures, and the pre−/post- four-phase study design. Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12621000380897. Registered 06 April 2021 - retrospectively registered, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381339&isReview=true


  • Open Access

    Improving health-related quality of life in women with breast, blood, and gynaecological Cancer with an eHealth-enabled 12-week lifestyle intervention: the women’s wellness after Cancer program randomised controlled trial

    by Charrlotte Seib, Debra Anderson, Amanda McGuire, Janine Porter-Steele, Nicole McDonald, Sarah Balaam, Diksha Sapkota, Alexandra L. McCarthy

    Background: The residual effects of cancer and its treatment can profoundly affect women’s quality of life. This paper presents results from a multisite randomized controlled trial that evaluated the clinical benefits of an e-health enabled health promotion intervention (the Women’s Wellness after Cancer Program or WWACP) on the health-related quality of life of women recovering from cancer treatment. Methods: Overall, 351 women previously treated for breast, blood or gynaecological cancers were randomly allocated to the intervention (WWACP) or usual care arms. The WWACP comprised a structured 12-week program that included online coaching and an interactive iBook that targeted physical activity, healthy diet, stress and menopause management, sexual wellbeing, smoking cessation, alcohol intake and sleep hygiene. Data were collected via a self-completed electronic survey at baseline (t0), 12 weeks (post-intervention, t1) and 24 weeks (to assess sustained behaviour change, t2). The primary outcome, health-related quality of life (HRQoL), was measured using the Short Form Health Survey (SF-36). Results: Following the 12-week lifestyle program, intervention group participants reported statistically significant improvements in general health, bodily pain, vitality, and global physical and mental health scores. Improvements were also noted in the control group across several HRQoL domains, though the magnitude of change was less. Conclusions: The WWACP was associated with improved HRQoL in women previously treated for blood, breast, and gynaecological cancers. Given how the synergy of different lifestyle factors influence health behaviour, interventions accounting for the reciprocity of multiple health behaviours like the WWACP, have real potential for immediate and sustainable change. Trial registration: The protocol for this randomised controlled trial was submitted to the Australian and New Zealand Clinical Trials Registry on 15/07/2014 and approved on 28/07/2014 (ACTRN12614000800628).


  • Open Access

    The Development of the Women’s Wellness Program for Irritable Bowel Syndrome

    by Bobbi Laing, Nikki Hart, Nette Scur, Janine Porter-Steele, Debra Anderson, Alan Fraser, Alexandra McCarthy

    Irritable bowel syndrome (IBS) is a chronic, relapsing, remitting functional disorder of the gut, characterised by abdominal pain, bloating, and changes in bowel habits, and associated with poor quality of life and depression. A common disorder in primary and specialty care, IBS affects 10–18% of New Zealanders and imposes significant personal, societal, and economic burdens. Although it is a condition of both mind and body, there is no holistic support program for people with IBS in Aotearoa. This project aimed: (1) To explore the impact of IBS with affected women and their health professionals. (2) Determine whether the Australian Women’s Wellness Program is adaptable, acceptable, and feasible for women in Aotearoa with IBS. (3) To codesign a prototype Women’s Wellness (IBS Aotearoa) program with affected women and their clinicians ready for feasibility testing. Eligible IBS participants (n = 15) comprising women 18 years or over, and legally able to consent, and separately health professionals or researchers (n = 15) working in the field of IBS participated in an in-depth individual or focus group interview. They were asked questions about their IBS journey, including diagnosis and treatment. Their feedback detailed how IBS adversely affected all aspects of quality of life, raised issues with diagnosis and treatment and articulated desired support approaches. When given information about the Women’s Wellness program and asked to provide feedback on it, all 30 interviewed participants agreed that a Women’s Wellness program health promotion approach for IBS was feasible, relevant, and warranted. A lifestyle program prototype based on the Women’s Wellness Program, tailored for those with IBS and led by an trained IBS health professional, is developed from these data ready for feasibility testing.

  • Alcohol and Breast Cancer

    by Sarah Balaam, Tom G. Bailey, Debra Anderson, James Retell, Alexandra L. McCarthy

    Background: There is evidence that drinking alcohol increases the risk of recurrent breast cancer. It is unclear whether Australian women with breast cancer are aware of this evidence or modify their alcohol intake accordingly. Objective: This article reports a secondary analysis of data from the Women's Wellness after Cancer Program (WWACP) randomized controlled trial (N = 351). The WWACP aimed to enhance quality of life and reduce chronic disease risk in women previously treated for cancer through lifestyle modification. Here we provide the alcohol-related data from the study's breast cancer participants (n = 269). We analyzed baseline alcohol consumption, the variables associated with alcohol intake, and intervention effect on intake at weeks 12 (end of intervention) and 24 (to determine sustainability). Interventions/Methods: Measures included the Dietary Questionnaire for Epidemiological Studies, Short Form-36, International Physical Activity Questionnaire, Green Climacteric Scale, Pittsburgh Sleep Quality Index, and Center for Epidemiologic Studies Depression Scale. Results: Most participants practiced safe alcohol consumption. Among drinkers, drinking caffeine, smoking, emotional and physical role limitations, and greater discomfort with vasomotor symptoms were associated with increased intake. Relative to baseline, alcohol consumption decreased from 5.22 g/d to 4.18 g/d in the intervention group, whereas consumption increased among control subjects at 12 weeks. No difference between groups was observed at week 24. Conclusion: The intervention was associated with less alcohol intake at week 12 among drinkers, but this reduction was not sustained at the 24-week follow-up. Implications for Practice: Future iterations of the WWACP will emphasize stronger messaging and supports regarding alcohol consumption after breast cancer treatment.